Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Ngā kaituhi matua: Xavier Sáez-Llorens (Author), Johnny Beltran-Rodriguez (Author), Jose M. Novoa Pizarro (Author), Ilhem Mensi (Author), Pavitra Keshavan (Author), Daniela Toneatto (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...